2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Area of Science:

• Cardiology
• Clinical Guidelines

Background:

• The Canadian Cardiovascular Society (CCS) regularly updates its guidelines for atrial fibrillation (AF) management.
• Advances in AF treatment necessitate focused reviews of new clinical data.

Purpose of the Study:

• To provide a focused update on key areas of atrial fibrillation management based on the latest evidence.
• To address clinically important advances in anticoagulation, cardioversion, ablation, and integrated care for AF patients.

Main Methods:

• Development of recommendations using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards.
• Comprehensive literature review of individual studies and existing evidence, assessing quality and bias.
• Inclusion of supplementary materials detailing the literature review process and evidence tables.

Main Results:

• The update covers seven key areas: anticoagulation during cardioversion, antithrombotic therapy in coronary artery disease, subclinical AF management, non-vitamin K antagonist oral anticoagulant reversal, acute pharmacological cardioversion, catheter ablation (including in heart failure), and integrated care for modifiable risk factors.
• Recommendations are presented with background information and rationale.
• The document links to a comprehensive summary of all CCS AF guidelines from 2010 to 2018.

Conclusions:

• The 2018 Focused Update provides current, evidence-based recommendations for atrial fibrillation management.
• These guidelines aim to improve patient outcomes by addressing critical advances in AF care.
• The integrated approach emphasizes managing modifiable cardiovascular risk factors in AF patients.